Abstract
Acute kidney injury (AKI) and sepsis carry consensus definitions. The simultaneous presence of both identifies septic AKI. Septic AKI is the most common AKI syndrome in ICU and accounts for approximately half of all such AKI. Its pathophysiology remains poorly understood, but animal models and lack of histological changes suggest that, at least initially, septic AKI may be a functional phenomenon with combined microvascular shunting and tubular cell stress. The diagnosis remains based on clinical assessment and measurement of urinary output and serum creatinine. However, multiple biomarkers and especially cell cycle arrest biomarkers are gaining acceptance. Prevention of septic AKI remains based on the treatment of sepsis and on early resuscitation. Such resuscitation relies on the judicious use of both fluids and vasoactive drugs. In particular, there is strong evidence that starch-containing fluids are nephrotoxic and decrease renal function and suggestive evidence that chloride-rich fluid may also adversely affect renal function. Vasoactive drugs have variable effects on renal function in septic AKI. At this time, norepinephrine is the dominant agent, but vasopressin may also have a role. Despite supportive therapies, renal function may be temporarily or completely lost. In such patients, renal replacement therapy (RRT) becomes necessary. The optimal intensity of this therapy has been established, while the timing of when to commence RRT is now a focus of investigation. If sepsis resolves, the majority of patients recover renal function. Yet, even a single episode of septic AKI is associated with increased subsequent risk of chronic kidney disease.
Similar content being viewed by others
References
KDIGO AKI Writing Group (2012) Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for acute kidney injury. Kidney Int 2(Suppl. 2):1–141
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative Workgroup (2004) Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) Group. Crit Care 8:R204–R212
Singer M, Deutschman CS, Seymour CW et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801–810
Kellum JA, Bellomo R, Ronco C (2016) Does this patient have acute kidney injury? An AKI checklist. Intensive Care Med 42:96–99
Bagshaw SM, Bennett M, Devarajan P, Bellomo R (2013) Urine biochemistry in septic and non-septic acute kidney injury: a prospective observational study. J Crit Care 28:371–378
Kellum JA, Sileanu FE, Murugan R, Lucko N, Shaw AD, Clermont G (2015) Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol 26:2231–2238
McCullough PA, Sahw AD, Haase M et al (2013) Diagnosis of acute kidney injury using funcitonal and injury biomarkers: workgroup statements from the tenth acute dialysis quality initiative consensus conference. Contrib Nephrol 182:13–29
Mårtensson J, Bellomo R (2014) The rise and fall of NGAL in acute kidney injury. Blood Purif 37:304–310
Mårtensson J, Xu S, Bell M, Martling CR, Venge P (2012) Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophils. Clin Chim Acta 413:1661–1667
Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, Krawczeski CD, Koyner JL, Murray P, Zappitelli M, Goldstein SL, Makris K, Ronco C, Mårtensson J, Martling CR, Venge P, Siew E, Ware LB, Ikizler A, Mertens PR (2011) The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury. J Am Coll Cardiol 57:1752–1761
Nickolas TL, Schmidt-Ott KM, Canetta P, Forster C, Singer E, Sise M, Elger A, Maarouf O, Sola-Del Valle DA, O’Rourke M, Sherman E, Lee P, Geara A, Imus P, Guddati A, Polland A, Rahman W, Elitok S, Malik N, Giglio J, El-Sayegh S, Devarajan P, Hebbar S, Saggi SJ, Hahn B, Kettritz R, Luft FC, Barasch J (2012) Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage. J Am Coll Cardiol 59:246–255
Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, Bihorac A, Birkhahn R, Cely CM, Chawla LS, Davison DL, Feldkamp T, Forni LG, Gong MN, Gunnerson KJ, Haase M, Hackett J, Honore PM, Hoste EA, Joannes-Boyau O, Joannidis M, Kim P, Koyner JL, Laskowitz DT, Lissauer ME, Marx G, McCullough PA, Mullaney S, Ostermann M, Rimmele T, Shapiro NI, Shaw AD, Shi J, Sprague AM, Vincent J-L, Vinsonneau C, Wagner L, Walker MG, Wilkerson RG, Zacharowski K, Kellum JA (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17:R25
Gomez H, Kellum JA (2016) Sepsis-induced acute kidney injury. Curr Opin Crit Care 22:546–553
Ronco C, Chawla LS (2016) Glomerular and tubular kidney stress test: new tools for a deeper evaluation of kidney function. Nephron 134:191–194
Wang E, Meier DJ, Sandoval RM, Von Hendy-Willson VE, Pressler BM, Bunch RM, Alloosh M, Sturek MS, Schwartz GJ, Molitoris BA (2012) A portable fiberoptic ratiometric fluorescence analyzer provides rapid point-of-care determination of glomerular filtration rate in large animals. Kidney Int 81:112–117
Bagshaw SM, Uchino S, Bellomo R et al (2007) Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2:431–439
Bouchard J, Acharya A, Cerda J et al (2015) A prospective international multicenter study of AKI in the intensive care unit. Clin J Am Soc Nephrol 10:1324–1331
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310
Vincent JL, Sakr Y, Sprung CL et al (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34:344–353
Poukkanen M, Vaara ST, Pettila V et al (2013) Acute kidney injury in patients with severe sepsis in Finnish intensive care units. Acta Anaesthesiol Scand 57:863–872
Gordon AC, Mason AJ, Thirunavukkarasu N et al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316:509–518
Haase-Fielitz Al, Haase M, Bellomo R, Dragun D (2007) Genetic polymorphisms in sepsis- and cardiopulmonary bypass-associated acute kidney injury. Contrib Nephrol 156:75–91
Zhao B, Lu Q, Cheng Y, Belcher JM et al (2017) A genome-wide association study to identify single nucleotide polymorphisms for acute kidney injury. Am J Respir Crit Care Med 195:482–490
Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R (2014) Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA 311:1308–1316
Wald R, McArthur E, Adhikari NK et al (2015) Changing incidence and outcomes following dialysis-requiring acute kidney injury among critically ill adults: a population-based cohort study. Am J Kidney Dis 65:870–877
Schrier RW, Wang W (2004) Acute renal failure and sepsis. N Engl J Med 351:159–169
Langenberg C, Wan L, Egi M et al (2006) Renal blood flow in experimental septic acute renal failure. Kidney Int 69:1996–2002
Di Giantomasso D, May CN, Bellomo R (2003) Vital organ blood flow during hyperdynamic sepsis. Chest 124:1053–1059
Langenberg C, Bellomo R, May C, Wan L, Egi M, Morgera S (2005) Renal blood flow in sepsis. Crit Care 9:R363–R374
Prowle JR, Molan MP, Henessy E, Bellomo R (2012) Measurement of renal blood flow by phase contrast magnetic resonance imaging during septic acute kidney injury: a pilot investigation. Crit Care Med 40:1768–1776
Verma SK, Molitoris BA (2015) Renal endothelial injury and microvascular dysfunction in acute kidney injury. Semin Nephrol 35:96–107
Post EH, Kellum JA, Bellomo R, Vincent J-L (2017) Renal perfusion in sepsis: from macro- to microcirculation. Kidney Int 91:45–60
Calzavacca P, Evans RG, Bailey M, Bellomo R, May CN (2015) Cortical and medullary tissue perfusion and oxygenation in experimental septic acute kidney injury. Crit Care Med 43:e431–e439
Lankadeva YR, Kosaka J, Evans RG, Bailey M, Bellomo R, May CN (2016) Intra-renal and urinary oxygenation during norepinephrine resuscitation in ovine septic acute kidney injury. Kidney Int 90:100–108
Casellas D, Mimran A (1979) Aglomerular pathways in intrarenal microvasculature of aged rats. Am J Anat 156:293–299
Dellepiane S, Marengo M, Cantaluppi V (2016) Detrimental cross-talk between sepsis and acute kidney injury: new pathogenic mechanisms, early biomarkers and targeted therapies. Crit Care 20:61
Mariano F, Cantaluppi V, Stella M et al (2008) Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care 12:R42
Doi K, Leelahavanichkul A, Yuen PST et al (2009) Animal models of sepsis and sepsis-induced kidney injury. J Clin Investig 119:2868–2878
Lerolle N, Nochy D, Guérot E et al (2010) Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration. Intensive Care Med 36:471–478
Takasu O, Gaut JP, Watanabe E et al (2013) Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Resp Crit Care Med 187:509–517
Langenberg C, Gobe G, Hood S et al (2014) Renal histopathology during experimental septic acute kidney injury and recovery. Crit Care Med 42:e58–e67
Maiden MJ, Otto S, Brealey JK et al (2016) Structure and function of the kidney in septic shock. A prospective controlled experimental study. Am J Resp Crit Care Med 194:692–700
Basu RK, Zappitelli M, Brunner L, Wang Y, Wong HR, Chawla LS et al (2014) Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children. Kidney Int 85(3):659–667
Honore PM, Nguyen HB, Gong M, Chawla LS, Bagshaw SM, Artigas A et al (2016) Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 for risk stratification of acute kidney injury in patients with sepsis. Crit Care Med 44(10):1851–1860
Colpaert K, Hoste EA, Steurbaut K, Benoit D, Van Hoecke S, De Turck F et al (2012) Impact of real-time electronic alerting of acute kidney injury on therapeutic intervention and progression of RIFLE class. Crit Care Med 40(4):1164–1170
Bagshaw SM, Goldstein SL, Ronco C, Kellum JA, Group AC (2016) Acute kidney injury in the era of big data: the 15(th) Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Can J Kidney Health Dis 3:5
Lachance P, Villeneuve P, Wilson FP, Selby FM, Featherstone RM et al (2016) Impact of e-alert for detection of acute kidney injury on processes of care and outcomes: protocol for a systematic review and meta-analysis. BMJ Open 5:e011152
Goldstein SL, Mottes T, Simpson K, Barclay C, Muething S, Haslam DB et al (2016) A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney Int 90:212–221
Bagshaw SM, Lapinsky S, Dial S, Arabi Y, Dodek P, Wood G et al (2009) Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 35:871–881
Kellum JA, Chawla LS, Keener C, Singbartl K, Palevsky PM, Pike FL et al (2016) The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock. Am J Respir Crit Care Med 193:281–287
Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, Jahan R, Harvey SE, Bell D, Bion JF, Coats TJ, Singer M, Young JD, Rowan KM (2015) Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 372:1301–1311
The ProCess Investigators (2014) A randomized trial of protocol-based care for early septic shock. N Engl J Med 370:1683–1693
Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, Cooper DJ, Higgins AM, Holdgate A, Howe BD, Webb SA, Williams P (2014) Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371:1496–1506
Gordon AC, Russell JA, Walley KR, Singer J, Ayers D, Storms MM et al (2016) The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med 36:83–91
Morelli A, Ricci Z, Bellomo R, Ronco C, Rocco M, Conti G et al (2005) Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial. Crit Care Med 33:2451–2456
Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lee J, Lo S, McArthur C, McGuiness S, Norton R, Myburgh J, Scheinkestel C, Su S (2012) An observational study fluid balance and patient outcomes in the randomized evaluation of normal vs. augmented level of replacement therapy trial. Crit Care Med 40:1753–1760
Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA (2011) Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 39:259–265
Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL (2006) Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354:2564–2575
Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL (2009) Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 76:422–427
Hjortrup PB, Haase N, Bundgaard H, Thomsen SL, Winding R, Pettila V, Aaen A, Lodahl D, Berthelsen RE, Christensen H, Madsen MB, Winkel P, Wetterslev J, Perner A, CLASSIC Trial Group, Scandinavian Critical Care Trials Group (2016) Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med 42:1695–1705
Lipscey M, Craig J, Suibiakto I et al (2015) Primary fluid bolus therapy for infection-associated hypotension in the emergency department. Crit Care Resusc 17:6–11
Lipscey M, Suibiakto I, Chiong J et al (2016) Secondary fluid bolus therapy for infection-associated hypotension. Crit Care Resusc 18:165–173
Bannard-Smith J, Alexander P, Glassford N et al (2015) Haemodynamic and biochemcial responses to fluid bolus therapy with human albumin solution, 4% versus 20% in critically ill adults. Crit Care Resusc 17:122–128
Yunos NM, Bellomo R, Glassford N, Sutcliffe H, Lam Q, Bailey M (2015) Chloride-liberal vs. chloride-restrictive intravenous fluid administration and acute kidney injury: an extended analysis. Intensive Care Med 41:257–264
Shaw AD, Raghunathan K, Peyerl FW, Munson SH, Paluszkiewicz SM, Schermer CR (2014) Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS. Intensive Care Med 40:1897–1905
Young P, Bailey M, Beasley R, Henderson S, Mackle D, McArthur C, McGuinness S, Mehrtens J, Myburgh J, Psirides A, Reddy S, Bellomo R, SPLIT Investigators, Anzics CTG (2015) Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. JAMA 314:1701–1710
Semler MW, Wanderer JP, Ehrenfeld JM, Stollings JL, Self WH, Siew ED, Wang L, Byrne DW, Shaw AD, Bernard GR, Rice TW, SALT Investigators and the Pragmatic Critical Care Research Group (2016) Balanced crystalloids versus saline in the intensive care unit: the SALT randomized Trial. Am J Resp Crit Care Med. doi:10.1164/rccm.201607-1345OC
Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R et al (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl Med 350:2247–2256
Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, Madsen KR, Moller MH, Elkjaer JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Soe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjaeldgaard AL, Fabritius ML, Mondrup F, Pott FC, Moller TP, Winkel P, Wetterslev J, 6S Trial Group, Scandinavian Critical Care Trials Group (2012) Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 367:124–134
Pisano A, Landoni G, Bellomo R (2016) The risk of infusing gelatin? Die-hard misconceptions and forgotten (or ignored) truths. Miner Anestesiol 82:1107–1114
Chawla LS, Busse L, Brasha-Mitchell E, Davison D, Honiq J, Alotaibi Z, Seneff MG (2014) Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study. Crit Care 18:534
Myburgh JA, Higgins A, Jovanovska A, Lipman J, Ramakrishnan N, Santamaria J (2008) A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 34:2226–2234
De Backer D, Aldecoa C, Njimi H, Vincent J-L (2012) Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Crit Care Med 40:725–730
Asfar P, Meziani F, Hamel JE et al (2014) High versus low blood pressure target in patients with septic shock. N Engl J Med 370:1583–1593
Payen D, Mateo J, Cavaillon JM, Fraisse F, Floriot C, Vicaut E (2009) Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit Care Med 37:803–810
Zhang P, Yang Y, Lv R, Zhang Y, Xie W, Chen J (2012) Effect of the intensity of continuous renal replacement therapy in patients with sepsis and acute kidney injury: a single-center randomized clinical trial. Nephrol Dial Transpl 27:967–973
Joannes-Boyau O, Honore PM, Perez P, Bagshaw SM, Grand H, Canivet JL, Dewitte A, Flamens C, Pujol W, Grandoulier AS et al (2013) High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med 39:1535–1546
Park JT, Lee H, Kee YK, Park S, Oh HJ, Han SH, Joo KW, Lim CS, Kim YS, Kang SW et al (2016) High-dose versus conventional-dose continuous venovenous hemodiafiltration and patient and kidney survival and cytokine removal in sepsis-associated acute kidney injury: a randomized controlled trial. Am J Kidney Dis 68:599–608
Zarbock A, Kellum JA, Schmidt C, Van Aken H, Wempe C, Pavenstadt H, Boanta A, Gerss J, Meersch M (2016) Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA 315:2190–2199
Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, Boyer A, Chevrel G, Lerolle N, Carpentier D et al (2016) Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 375:122–133
RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J et al (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361:1627–1638
Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM et al (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:7–20
Roberts DM, Liu X, Roberts JA, Nair P, Cole L, Roberts MS, Lipman J, Bellomo R (2015) A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics. Crit Care 13(19):84
Caironi P, Tognoni G, Masson S et al (2014) Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 370:1412–1421
Peters E, Mehta RL, Murray PT, Hummel J, Joannidis M, Kellum JA, Arend J, Pikkers P (2016) Study protocol for a multicentre randomised controlled trial: safety, tolerability, efficacy, and quality of life of a human recombinant alkaline phosphatase in patients with sepsis-associated acute kidney injury. BMJ Open 6:e012371
Chawla LS, Russell JA, Bagshaw SM et al (2017) Angiotensin for the treatment of high output shock 3 (ATHOS-3): a study protocol for a phase 3, double-blind, randomized controlled trial. Crit Care Resusc 2017 19:43–49.
Venot M, Weis L, Clec’h C, Darmon M, Allaouchiche B, Goldgran-Toledano D, Garrouste-Orgeas M, Adrie C, Timsit JF, Azoulay E (2015) Acute kidney injury in severe sepsis and septic shock in patients with and without diabetes mellitus: a multicenter study. PLoS One 10:e0127411
Wald R, Quinn RR, Adhikari NK et al (2012) Risk of chronic dialysis and death following acute kidney injury. Am J Med 125:585–593
Pickkers P, Ostermann M, Joannidis M, Zarbock A, Hoste E, Bellomo R, Prowle J, Darmon M, Bonventre JV, Forni L, Bagshaw SM, Schetz M (2017) The intensive care medicine agenda on acute kidney injury. Intensive Care Med. doi:10.1007/s00134-017-4687-2
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Dr. Kellum and Dr. Ronco have received grants and consultation fees from Astute. Dr. Bellomo has received grants from Baxter and Braun.
Additional information
Take-home message: Septic acute kidney injury is no longer considered a disease of the macrocirculation, but rather a disorder of the renal microcirculation with associated inflammatory tubular injury. These new ideas have profound diagnostic and therapeutic implications.
Rights and permissions
About this article
Cite this article
Bellomo, R., Kellum, J.A., Ronco, C. et al. Acute kidney injury in sepsis. Intensive Care Med 43, 816–828 (2017). https://doi.org/10.1007/s00134-017-4755-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-017-4755-7